Bioventus Inc -A-
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bioventus Inc -A-
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
Frequently asked questions
To buy Bioventus Inc -A- stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bioventus Inc -A- by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bioventus Inc -A- is BVS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bioventus Inc -A- has its primary listing on NASDAQ. You can trade Bioventus Inc -A- with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bioventus Inc -A- is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bioventus Inc -A- as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bioventus Inc -A-.